News

ABC Action News31m
FDA mandates stricter warning labels on opioids to address long-term use risks
The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction ...
FDA Vaccine Chief Steps Down After Controversial Tenure
During his first term, Trump signed the “Right to Try” law, which allows terminally ill patients to seek treatments that ...
Fish recall sparks FDA risk warning
Moon N Sea Ga Llc. issued a voluntary recall on June 24 for various fish products after they were potentially produced under ...
FDA's top vaccine official leaves agency after controversial decisions
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
STAT2d
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.
FDA Issues Most Serious Risk Level for Cookie Recall
The FDA issued a Class I warning after California-based Jalux Americas, Inc. recalled cookie products because of potential undeclared allergens ...
Healio1d
FDA approves vagus nerve stimulator for rheumatoid arthritis
The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...
STAT23h
FDA to stress opioids’ risk of overdose, death in new medication safety labels
The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure.
US FDA declines to approve Regeneron's blood cancer therapy for second time
Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, ...